Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Obagi Medical launches new ELASTIderm system
Formulated with a unique combination of ingredients, it is designed to treat mottled hyperpigmentation, including age spots and freckles, while reducing the appearance of fine lines and wrinkles
Formulated with a unique combination of ingredients, it is designed to treat mottled hyperpigmentation, including age spots and freckles, while reducing the appearance of fine lines and wrinkles
This investigational new drug (IND) application represents the second IND filed by the company in 2007 for MSI- 1436 (trodusquemine). MSI-1436 is a novel therapeutic acts by regulating
The NIH sponsored study will examine maintenance of hemoglobin, iron parameters, need for intravenous iron and oxidative stress markers in patients receiving soluble ferric pyrophosphate (SFP) via dialysate
NovaDel has submitted its ZolpiMist (zolpidem tartrate) application using the FDA’s 505(b)(2) process based on data from two randomized, open-label, dose-ranging studies comparing ZolpiMist with Ambien tablets in
Most recently, Mr Ostrov was company group chairman, Worldwide Vision Care, for Johnson & Johnson, where he led the company’s global Vision Care businesses from 1998 to 2006.
Allergy sufferers can now find Zyrtec-D 12-HOUR and Zyrtec in stores in the original prescription strength. Zyrtec is a once-a-day medication for adults and children that provide 24
Under the terms of the agreement, pSivida has sold and licensed intellectual property and other assets concerned with nutrient delivery, food packaging and personal care applications of BioSilicon
Under the terms of the collaboration, Direvo will apply its proprietary protein-engineering capabilities to create specifically engineered proteases. MedImmune will then be responsible for the development and marketing
With this capital, the company intends to accelerate the FDA approval process and expand its marketing efforts, in order to launch its first product during the H2 of
The company may sell its common stock to Fusion Capital from time to time over a 24-month period after the Securities and Exchange Commission (SEC) has declared effective